Wang Xiaodong
SEC Form 4 insider trading activity
Wang Xiaodong has filed 7 SEC Form 4 filings (36 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 15, 2026.
On the most recent filing, Wang Xiaodong is listed as Director at BeOne Medicines Ltd. Inside the rolling window, Wang Xiaodong reported no open-market purchases and 3 open-market sales totaling $35.6M in ONC. The largest disclosed transaction in the window is a sale of 38,287 ONC shares on Sep 8, 2026, worth $13.4M.
Companies traded
Other insiders at ONC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$35.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wang Xiaodong made?
Wang Xiaodong has filed 7 SEC Form 4 filings (36 transaction rows) across 1 company since 2025.
Which companies does Wang Xiaodong trade?
Wang Xiaodong has filed SEC Form 4 disclosures for 1 company, including ONC.
When was Wang Xiaodong's most recent SEC Form 4 filing?
Wang Xiaodong's most recent SEC Form 4 filing on Tracefour is dated Oct 15, 2026.
What is Wang Xiaodong's total buy and sell value in the current window?
Inside the rolling retention window, Wang Xiaodong bought $0 and sold $35.6M based on SEC Form 4 filings.
What was Wang Xiaodong's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 38,287 ONC shares on 2026-09-08, worth $13.4M, per SEC Form 4 filings.